Stay updated on Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.3, was added to the record history, replacing the previous v3.6.2. This reflects a site-level update to the page rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-07-03T23:53:14.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.2) was added to the record history and the older revision (v3.6.0) was removed, updating the study record's version history.
    Difference
    0.1%
    Check dated 2026-06-27T00:10:53.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Adds the responsible party’s name and affiliation to the record history and introduces new metadata fields (Last verified, Last known status was, Revision: v3.6.0).
    Difference
    3%
    Check dated 2026-06-12T15:43:19.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The record history now shows Revision: v3.5.5, updating from the previous v3.5.4. This reflects a new page version rather than a change to study data.
    Difference
    0.1%
    Check dated 2026-06-05T10:23:08.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The latest revision shown on the page is v3.5.4, replacing the previous v3.5.3 in the history. This indicates a small administrative update to the page revision tracking and footer information.
    Difference
    0.1%
    Check dated 2026-05-14T23:14:09.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page’s revision label updates from v3.5.2 to v3.5.3, indicating a small site update. No study details or record content are modified.
    Difference
    0.1%
    Check dated 2026-04-30T18:50:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.